01 November 2018
RegMedNet announces latest winner of the Award for Cultivating Excellence
This year saw more nominations than ever, from Belgium to Brazil,
recognizing the depth and breadth of excellence in regenerative medicine
November 01, 2018 – RegMedNet has today announced the winner of this year’s Award for Cultivating Excellence. BellaSeno GmbH (Leipzig, Germany) impressed the public with their “innovation, creativity, professionalism and investment in young professionals”, according to one voter.
BellaSeno is a preclinical stage medical device company developing innovative porous bioresorbable breast implants. The company was founded in 2015by a team of biomedical engineers and plastic surgeons from India, Australia and Germany, and is based in the BioCity incubator, Leipzig, Germany. The company has received substantial financial support from the Saxony Development Bank (SAB) and the European Fund for Regional Development.
Their nominator cited their belief that "in order for Additive Manufacturing (sic) to reach its true potential in the field of medicine, training of young engineers and biologists is of paramount importance…[and] the students are awarded authorship in all publications and patents that directly result from their work at BellaSeno" as some of the reasons for the nomination.
BellaSeno GmbH won the public vote after five finalists were shortlisted by an expert judging panel; the other finalists included the StaalLab (Leiden University Medical Center, the Netherlands), the Biotechnology Unit, University of Suffolk (UK), Roger Barker’s lab (University of Cambridge, UK) and the Yin Laboratory, MDI Biological Laboratory (ME, USA).
This second year of the Award saw almost 50 labs around the world nominate themselves, or be nominated; an increase in 16% in 2017. This year also saw the introduction of a public vote, with almost 1000 votes cast for the five finalists. Find out more about the nominees in an interactive infographic.
The Award for Cultivating Excellence was established in 2017 in the belief that that the most valuable players in regenerative medicine aren't always those seen in the news. As well as ground-breaking research and award-winning facilities, RegMedNet wanted to recognize achievement in other areas, such as career development and scientific outreach.
To highlight the achievements of BellaSeno GmbH, they will be the subject of a one-month-long special feature on RegMedNet, featuring interviews with lab members and selected published research. They will also receive one year-long subscription to a Future Science Group title of their choice, and 50% off open access fees for up to five articles published in Regenerative Medicine.
“It’s been a pleasure this year to learn about even more fantastic labs around the world”, commented RegMedNet Publisher, Freya Leask. “I’d like to congratulate BellaSeno GmbH and all of this year’s nominees for their inspiring work and huge contributions to the field of regenerative medicine.”
Applications for next year’s award will open in spring 2019. Sign up to RegMedNet today so you don’t miss this important date.
Visit the lab feature on RegMedNet here.
About Future Science Group
Founded in 2001, Future Science Group (FSG) is a progressive publisher focused on breakthrough medical, biotechnological, and scientific research. FSG’s portfolio includes two imprints, Future Science and Future Medicine. Both publish eBooks and journals. In addition to this core publishing business, FSG develops specialist eCommunities. Key titles and sites include Bioanalysis Zone, Epigenomics, Nanomedicine, and the award-winning Regenerative Medicine.
The aim of FSG is to service the advancement of clinical practice and drug research by enhancing the efficiency of communications among clinicians, researchers, and decision-makers, and by providing innovative solutions to their information needs. This is achieved through a customer-centric approach, use of new technologies, products that deliver value-for-money and uncompromisingly high standards.
RegMedNet is a community site that unites the diverse regenerative medicine community. Through partnership with our sister journal, Regenerative Medicine, we seek to educate and inspire to help this exciting field move forward at an even faster rate. On RegMedNet, you can find free educational webinars, expert opinion and insight, and exclusive peer-reviewed journal articles, as well as the latest news and advances. RegMedNet members have the opportunity to connect and collaborate with industry leaders and academic experts as well as publish their own articles without the wait.